Floxuridine
NDC 63323-145, FLOXURIDINE, injection, powder, lyophilized, for solution, from Fresenius Kabi USA, LLC.
- Product NDC
- 63323-145
- Status
- Listed
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRA-ARTERIAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA075837
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63323-145 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FLOXURIDINE500 mg/5mL
Pharmacologic classes
Antimetabolite [EPC]; Deoxyuridine [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63323-145-07 | 63323014507 | 1 VIAL in 1 CARTON (63323-145-07) / 5 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c8edabc1-67cd-421b-a147-7c1f19f05b8e
Use it
Look up 63323-145 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63323-145 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63323-145. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.